---
title: "CLSA: ASMPT  2Q Adjusted Profit Beats Expectations, Maintains Outperform Rating"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294305033.md"
description: "CLSA reports ASMPT's Q2 adjusted profit of HKD638 million, beating expectations by 76% due to strong revenue and margins. Orders reached HKD7.08 billion with a 1.43x book-to-bill ratio. The broker raised its 2026 earnings forecast by 17%, set a target price of HKD226.2 based on a 35x 2027 P/E, and maintained an Outperform rating for the stock."
datetime: "2026-07-30T05:22:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294305033.md)
  - [en](https://longbridge.com/en/news/294305033.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294305033.md)
generator: "portal-rs"
---

# CLSA: ASMPT  2Q Adjusted Profit Beats Expectations, Maintains Outperform Rating

CLSA released a report stating that ASMPT (00522.HK) +0.300 (+0.219%) Short selling $19.59M; Ratio 5.023% 's adjusted net profit for 2Q reached HKD638 million, 76% above market expectations, benefiting from strong revenue and gross margin. Revenue during the period was HKD4.94 billion, 10.5% above the midpoint of the company's guidance; orders reached HKD7.08 billion, significantly outperforming the company's expectations for its semiconductor and SMT businesses, with a book-to-bill ratio of 1.43x; adjusted gross margin was 42.5%, 2.8 ppts above market expectations.

The report stated that 3Q revenue guidance is USD630 million to USD690 million, with a midpoint of USD660 million, representing YoY growth of 46% and QoQ growth of 5%, 10% above market expectations. Management expects orders in 3Q to record high-single-digit QoQ growth, mainly driven by thermocompression bonding and optical communications businesses. The thermocompression bonding business achieved strong order momentum from advanced logic and memory customers, while revenue from optical transceiver solutions recorded steady growth.

CLSA raised its 2026 earnings forecast by 17%, while largely maintaining its earnings forecasts for 2027 and 2028 unchanged. Based on a target valuation of 35x 2027 forecast P/E ratio, the broker set a TP of HKD226.2 and maintained its Outperform rating. (ad/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-07-30 12:25.)

### Related Stocks

- [00522.HK](https://longbridge.com/en/quote/00522.HK.md)

## Related News & Research

- [ASMPT  Interim Net Profit Surges Nearly 1.75x to HKD589 Million; Declares Interim DPS of HKD0.97](https://longbridge.com/en/news/294133223.md)
- [ASMPT declares interim dividend of HKD 0.97 per share for first half of 2026](https://longbridge.com/en/news/294123800.md)
- [ASMPT Projects 3Q Gross Margin to Remain Stable at ~40%; TCB Remains Core Growth Driver](https://longbridge.com/en/news/294144018.md)
- [ASMPT schedules board meeting to review interim results, consider dividend](https://longbridge.com/en/news/292459049.md)
- [CCB Intl. Sticks to Their Buy Rating for ASMPT Ltd (ASMVF)](https://longbridge.com/en/news/294580572.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**